Peginterferon -2a (40kD) [Pegasys ® ] Improves HR-QOL Outcomes Compared with Unmodified Interferon -2a [Roferon ® -A]: In Patients with Chronic Hepatitis C

Author： Rasenack J.  

Publisher： Adis International

ISSN： 1170-7690

Source： PharmacoEconomics, Vol.21, Iss.5, 2003-01, pp. : 341-349

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Peginterferon- -2a (40kD) Plus Ribavirin: A Review of its Use in the Management of Chronic Hepatitis C

By Keating G.M.   Curran M.P.  

Drugs, Vol. 63, Iss. 7, 2003-01 ,pp. : 701-730

Adis International

Access to resources Recommend Favorite

Peginterferon- -2a (40kD): A Review of its Use in the Management of Chronic Hepatitis C

By Perry C.M.   Jarvis B.  

Drugs, Vol. 61, Iss. 15, 2001-01 ,pp. : 2263-2288

Adis International

Access to resources Recommend Favorite

Peginterferon-α-2a (40kD): A Review of its Use in the Management of Patients with Chronic Hepatitis B

By Robins Gayle W.   Scott Lesley J.   Keating Gillian M.  

Drugs, Vol. 65, Iss. 6, 2005-01 ,pp. : 809-825

Adis International

Access to resources Recommend Favorite

Peginterferon-α-2a (40 kD) Plus Ribavirin: A Review of its Use in the Management of Chronic Hepatitis C Mono-Infection

By Keam Susan J.   Cvetković Risto S.  

Drugs, Vol. 68, Iss. 9, 2008-01 ,pp. : 1273-1317

Adis International

Access to resources Recommend Favorite

Peginterferon-α-2a (40 kD): A Review of its Use in Chronic Hepatitis B

By Keating Gillian M.  

Drugs, Vol. 69, Iss. 18, 2009-12 ,pp. : 2633-2660

Adis International

Access to resources Recommend Favorite